Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules

· Pontificia Universidade Católica do Rio Grande do Sul

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules, covering 2025-06-05 to 2025-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules as Enhancers of Bone Formation in Bone Grafting [Phase 1, Phase 2]

See pricing